Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 9 September 1994:
Vol. 265. no. 5178, pp. 1582 - 1584
DOI: 10.1126/science.7521539

Articles

Science, Vol 265, Issue 5178, 1582-1584
Copyright © 1994 by American Association for the Advancement of Science


articles

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

KM Dameron, OV Volpert, MA Tainsky, and N Bouck

Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, IL 60611.

As normal cells progress toward malignancy, they must switch to an angiogenic phenotype to attract the nourishing vasculature that they depend on for their growth. In cultured fibroblasts from Li-Fraumeni patients, this switch was found to coincide with loss of the wild-type allele of the p53 tumor suppressor gene and to be the result of reduced expression of thrombospondin-1 (TSP-1), a potent inhibitor of angiogenesis. Transfection assays revealed that p53 can stimulate the endogenous TSP-1 gene and positively regulate TSP-1 promoter sequences. These data indicate that, in fibroblasts, wild-type p53 inhibits angiogenesis through regulation of TSP-1 synthesis.





ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)